You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 8, August 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Case of Bullous Pemphigoid and Transitional Cell Carcinoma of the Bladder

Demonstration of a Circulating Factor Reactive With Basement Membrane Zone of Skin and of Bladder Carcinoma

Toshihiro Tanaka, MD; Atsuhiko Ogino, MD; Keiji Ogura, MD; Kiyohide Nakagawa, MD

Arch Dermatol. 1983;119(8):704-705.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The association of bullous pemphigoid (BP) with internal malignant neoplasms has occasionally been reported.1,2 We describe herein a patient who had coexistent BP and transitional cell carcinoma (TCC) of the bladder. The patient's serum contained antibody reactive with the basement membrane zone (BMZ) of the skin and the TCC as detected by the complement immunofluorescence (IF) microscopy technique. To our knowledge, this is the first such case reported in the English literature.

Report of a Case

In July 1980, a 54-year-old woman was admitted to the urology clinic of the Kyoto (Japan) National Hospital, because of hematuria. A biopsy specimen from the bladder showed the microscopic changes of TCC, grade 2. After the patient underwent a partial cystectomy, 200 mg/day of oral fluorouracil was given for six months. In July 1981, the patient was rehospitalized because of hematuria and enlargement of the tumor, which was found on cystoscopic examination. . . . [Full Text PDF of this Article]


Author Affiliations

From the Departments of Dermatology (Drs Tanaka and Ogino) and Urology (Drs Ogura and Nakagawa), Kyoto (Japan) National Hospital.


Footnotes

Reprint requests to Department of Dermatology, Faculty of Medicine, Kyoto University, Shogoin, Sakyo-ku, Kyoto 606, Japan (Dr Tanaka).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.